/605033.SS

605033.SS Stock - Shaanxi Meibang Pharmaceutical Group Co., Ltd.

Q: What is the analyst price target for 605033.SS?

Analyst price target information is not currently available for 605033.SS.

Q: What is 605033.SS's market cap?

Market capitalization information is not currently available for 605033.SS.

Basic Materials|Agricultural Inputs|SHH

$19.79+0.46%

+$0.09 (+0.46%) • Dec 26

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $21.77

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for 605033.SS

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.55

52W High$32.86

52W Low$11.76

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$885.53M	$699.03M	$906.05M	$842.49M	$568.52M
Gross Profit	$252.79M	$220.99M	$377.23M	$322.43M	$200.49M
Gross Margin	28.5%	31.6%	41.6%	38.3%	35.3%
Operating Income	$30.64M	$50.37M	$140.27M	$122.50M	$87.59M
Net Income	$36.86M	$57.56M	$145.09M	$125.74M	$78.73M
Net Margin	4.2%	8.2%	16.0%	14.9%	13.8%
EPS	$0.27	$0.43	$1.07	$1.14	$0.78

Company Overview

Shaanxi Meibang Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of pesticide preparations. Its products include fungicides and insecticides. The company was founded in 1998 and is based in Weinan, China.

Visit Website

Earnings History & Surprises

605033.SS

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$0.03

Q2 2023

EPS Surprise History

Q1 23

No data

Q2 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2023	Jun 30, 2023	—	$0.03	—	—
Q1 2023	Mar 31, 2023	—	$0.51	—	—

Frequently Asked Questions about 605033.SS

What is 605033.SS's current stock price?

Shaanxi Meibang Pharmaceutical Group Co., Ltd. (605033.SS) is currently trading at $19.79 per share. The stock has moved +0.46% today.

What is the analyst price target for 605033.SS?

No analyst price targets are currently available for this stock.

What sector is Shaanxi Meibang Pharmaceutical Group Co., Ltd. in?

Shaanxi Meibang Pharmaceutical Group Co., Ltd. operates in the Basic Materials sector, specifically within the Agricultural Inputs industry. The company is traded on the SHH exchange.

What is 605033.SS's market cap?

Shaanxi Meibang Pharmaceutical Group Co., Ltd. has a market capitalization of $2.68 billion, making it a mid-cap company.

Does 605033.SS pay dividends?

No, Shaanxi Meibang Pharmaceutical Group Co., Ltd. does not currently pay a dividend to shareholders.